Pancreatic Cancer Research

ResearcherKansai Medical UniversityActive in the last 2 years

Kazuichi Okazaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-3424-3142; OpenAlex author ID A5015485871. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
84
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 4 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 14

  1. Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide propensity score-matched analysis. Co-author DOI 10.1016/j.gie.2026.05.032↗
  2. Clinical Statistics and Outcomes of Pancreatic Neoplasms in Japan: A Retrospective Cohort Study Using the Japan Pancreatic Cancer Registry. Co-author DOI 10.1097/mpa.0000000000002694↗
  3. Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection: A Nationwide Project Study of Japan Pancreas Society. Co-author DOI 10.1097/sla.0000000000006444↗
  4. Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasoun… Last author DOI 10.1007/s00428-021-03236-w↗
  5. Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Co-author DOI 10.1016/j.pan.2021.03.007↗
  6. Usefulness of half-covered metallic stent placement in preventing acute cholecystitis complication in pancreatic cancer-induced distal biliary stricture. Co-author DOI 10.1002/jgh3.12409↗
  7. Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis. Last author DOI 10.1097/mpa.0000000000001513↗
  8. Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study. Last author DOI 10.1097/mpa.0000000000001579↗
  9. Effectiveness of Photodynamic Screening Using 5-Aminolevulinic Acid for the Diagnosis of Pancreatic Cancer. Last author DOI 10.21873/anticanres.14347↗
  10. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nat… Last author DOI 10.1016/j.surg.2019.06.023↗
  11. Diffuse Pancreatic Cancer Mimicking Autoimmune Pancreatitis. Last author DOI 10.2169/internalmedicine.2689-19↗
  12. Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis. Last author DOI 10.1097/mpa.0000000000000816↗
  13. Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience. Last author DOI 10.1016/j.pan.2014.04.029↗
  14. The similarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltration. Last author DOI 10.1007/s00535-012-0677-x↗

Closest collaborators

The 25 strongest of 84 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sohei Satoi · 6 shared papers, 2013–2026 · strength 0.81
  2. Atsushi Masamune · 5 shared papers, 2019–2026 · strength 0.78
  3. Michiaki Unno · 4 shared papers, 2019–2026 · strength 0.70
  4. Yoshifumi Takeyama · 3 shared papers, 2025–2026 · strength 0.62
  5. Takao Itoi · 4 shared papers, 2019–2026 · strength 0.62
  6. Tsukasa Ikeura · 7 shared papers, 2013–2022 · strength 0.57
  7. Shin Hamada · 3 shared papers, 2019–2026 · strength 0.54
  8. Shinichi Egawa · 3 shared papers, 2019–2026 · strength 0.54
  9. Masamichi Mizuma · 3 shared papers, 2019–2026 · strength 0.54
  10. Kohei Nakata · 2 shared papers, 2026 · strength 0.47
  11. Ichiro Yasuda · 2 shared papers, 2026 · strength 0.47
  12. Manabu Kawai · 2 shared papers, 2026 · strength 0.47
  13. Ken Shirabe · 2 shared papers, 2026 · strength 0.47
  14. Makoto Takaoka · 5 shared papers, 2013–2020 · strength 0.36
  15. Hideaki Miyoshi · 5 shared papers, 2013–2020 · strength 0.36
  16. Tamotsu Kuroki · 3 shared papers, 2019–2025 · strength 0.31
  17. Hisato Igarashi · 3 shared papers, 2019–2025 · strength 0.31
  18. Hidetoshi Eguchi · 3 shared papers, 2019–2025 · strength 0.31
  19. Hiroki Yamaue · 3 shared papers, 2019–2025 · strength 0.31
  20. Masaji Tani · 3 shared papers, 2019–2025 · strength 0.31
  21. Tsutomu Fujii · 3 shared papers, 2019–2025 · strength 0.31
  22. Yoshiki Hirooka · 3 shared papers, 2019–2025 · strength 0.31
  23. Tooru Shimosegawa · 2 shared papers, 2017–2026 · strength 0.30
  24. Keiji Hanada · 3 shared papers, 2017–2020 · strength 0.27
  25. Toru Furukawa · 2 shared papers, 2022–2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.